You are here

  • Home
  • Archive
  • Volume 19, Issue 6
  • Balancing competing risks: perinatal exposure to macrolides increases the risk of infantile hypertrophic pyloric stenosis

Article Text

Article menu
Download PDFPDF
Harm
Cohort study
Balancing competing risks: perinatal exposure to macrolides increases the risk of infantile hypertrophic pyloric stenosis
  1. Margaret A Honein,
  2. Janet D Cragan
  1. Centers for Disease Control and Prevention, Atlanta, Georgia, USA
  1. Correspondence to : Dr Margaret A Honein, Centers for Disease Control and Prevention, Mailstop E-86, 1600 Clifton Road, Atlanta, GA 30333, USA; mhonein{at}cdc.gov

https://doi.org/10.1136/ebmed-2014-110015

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Lund M, Pasternak B, Davidsen RB, et al. Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study. BMJ 2014;348:g1908.OpenUrlAbstract/FREE Full Text

    Context

    Infantile hypertrophic pyloric stenosis (IHPS) is a potentially life-threatening condition for which surgical treatment yields excellent patient outcomes.1 However, the aetiology of IHPS remains elusive. Prior studies have implicated early neonatal exposure to erythromycin as a strong risk factor for IHPS, but it is less clear whether maternal use in late pregnancy or while breastfeeding also poses a risk.2 Perinatal exposure to macrolide antibiotics is not uncommon. About 1% of pregnant women report use in the third trimester, and while no macrolides are licensed by the US Food and Drug Administration for use in infants less …

    View Full Text

    Footnotes

    • Competing interests None.

    • Disclaimer The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

    • Provenance and peer review Commissioned; internally peer reviewed.